Here is the following brief of all the major highlights from Tuesday, October 8. Bookings for the Mahindra Thar Roxx have ...
Tharimmune, Inc. (Nasdaq:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company committed to pioneering therapies in immunology and inflammation, today announced plans for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback